United States · FDA National Drug Code directory

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
51407-561_534bb169-91a1-25f6-e063-6294a90a1297
Product NDC
51407-561
Form
CAPSULE, EXTENDED RELEASE
Composition / generic term
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate
Labeler
Golden State Medical Supply, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20211126
Source listing expiry
20271231

Source-listed ingredients

  • AMPHETAMINE SULFATE — 6.25 mg/1
  • DEXTROAMPHETAMINE SULFATE — 6.25 mg/1
  • DEXTROAMPHETAMINE SACCHARATE — 6.25 mg/1
  • AMPHETAMINE ASPARTATE MONOHYDRATE — 6.25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51407-561-01) · 51407-561-01

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate — United States | Molindra Medicines